Highlighting the City’s commitment to life sciences industry
innovator in biopharmaceutical drug delivery solutions, to our city. This move marks a significant milestone for Cedar Park, highlighting our commitment to fostering a thriving business community and supporting cutting-edge advancements in healthcare technology.
Zeteo Biomedical, renowned for its pioneering research and development of drug and biologic delivery device technology, has chosen Cedar Park as its new home. Zeteo partners with global pharmaceutical and biotech organizations to develop therapeutics for the treatment of infectious diseases threatening public health as well as neurodegenerative autoimmune and ocular disorders. The company’s relocation not only underscores Cedar Park’s attractiveness as a business hub but also promises exciting opportunities for collaboration and job creation within the local community.
“We are delighted to welcome Zeteo Biomedical to Cedar Park,” said Arthur Jackson, Chief Economic Development Officer. “Their decision to relocate here reflects the energetic and supportive environment our city offers for businesses of all sizes. We look forward to the positive impact Zeteo Biomedical will have on our community, and we are committed to supporting their continued success.”
Zeteo Biomedical’s Founder and CEO, Timothy Sullivan, expressed enthusiasm about the move, stating, “Cedar Park’s strategic location make it an ideal place for Zeteo Biomedical to continue our mission of protecting the quality of human life through the innovation of products addressing
unmet medical needs of the global population. We are energized to be part of this dynamic
The relocation marks a significant step in Cedar Park’s strategic initiative to establish a thriving life sciences cluster in the Austin, Texas region, creating an environment that fosters investment and growth for companies in the sector.
About Zeteo Biomedical:
Zeteo Biomedical™ is a leading biomedical device technology company headquartered in Cedar Park, Texas. The company provides novel technology and technical services supporting the development and commercialization of drug/device combination products, and fill/finish packaging solutions for pharmaceuticals, biopharmaceuticals, biologics, and botanicals. Zeteo’s technology applications include drug/device combination products for intranasal, nose-to-brain, ophthalmic, sublingual, and animal care applications. For more information, visit Zeteo’s website at www.zeteobiomed.com.
community and look forward to contributing to its growth and success.”
Date: January 23, 2025
Contact: Dan Sousa, City of Cedar Park Community Affairs Assistant Director
737-222-0098, daniel.sousa@cedarparktexas.gov
Contact: Michael Snyder, Zeteo Biomedical Media Coordinator
512-614-0144, zeteo@zeteobiomed.com
